Previous 10 | Next 10 |
BioLife Solutions' (BLFS) SciSafe division has been awarded a two year contract, worth ~$2.7M, from a large pharmaceutical company for cold chain management and storage of COVID-19 vaccines.Management estimates that SciSafe will contribute ~ $9M in incremental revenue in 2021.Quick look at hi...
BioLife Solutions SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines PR Newswire BOTHELL, Wash., Oct. 14, 2020 BOTHELL, Wash. , Oct. 14, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("Bi...
BioLife Solutions Closes Acquisition of SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry Transaction Expected to Add $9 Million in Revenue in 2021 PR Newswire BOTHELL, Wash., Oct. 1, 2020 BOTHELL, Wash. , Oct. 1, ...
Q2 2020 was a stellar quarter for BLFS in terms of revenue generation and new customer onboarding. Despite the rough patches on the profitability side, analysts seem to be optimistic about its ability to grow earnings in the future with an estimated annual growth rate of 47%. Ther...
BioLife Solutions (NASDAQ: BLFS) is starting the week with a bang. On Monday morning, the company announced it has signed a definitive agreement to purchase privately held SciSafe. The price is $30 million, which will be paid half in cash and half in newly issued BioLife common shar...
BioLife Solutions (BLFS) to acquire SciSafe, a privately held multi-facility provider of biological materials storage to the cell and gene therapy and pharmaceutical industries for $15M in cash and $15M in newly issued shares.SciSafe is also eligible to receive additional 626K shares over the...
BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry Transaction Expected to Add $9 Million in Revenue in 2021 PR Newswire BOTHELL, Wash., Sept. 21, 2020 BOTHELL, Wash. , Sept. 21, 2020 /PRN...
BioLife Solutions ( BLFS +5.2% ) initiated at Cowen with Outperform, PT $33, indicating the stock is significantly undervalued; currently hovering around 52-week high levels gained 166% in past 6 months trading. More news on: BioLife Solutions, Inc., Healthcare stocks news, Stoc...
BOTHELL, Wash. , Aug. 25, 2020 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, was recently named one of the 100 Best Co...
Biolife Solutions, Inc. (BLFS) Q2 2020 Earnings Conference Call August 06, 2020, 16:30 ET Company Participants Roderick de Greef - CFO, COO & Secretary Michael Rice - President, CEO & Director Conference Call Participants Jacob Johnson - Stephens Inc. Marc Wiesenber...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...